Results 221 to 230 of about 234,539 (335)

In Vivo Biosynthesis and Direct Incorporation of Noncanonical Amino Acids into Proteins

open access: yesChemBioChem, EarlyView.
This review evaluates engineered (semi)autonomous cell systems for the biosynthesis and incorporation of noncanonical amino acids (ncAAs) into proteins. While semi‐autonomous cells convert supplied precursors into ncAAs autonomous cells integrate biosynthetic pathways that produce these building blocks intracellularly.
Jan Hendrik Illies   +2 more
wiley   +1 more source

Overall Survival of Patients With Pyruvate Kinase Deficiency in the UK: A Real-World Study. [PDF]

open access: yesEJHaem
Foy P   +11 more
europepmc   +1 more source

Isoenzymes of Pyruvate Kinase in Etioplasts and Chloroplasts [PDF]

open access: bronze, 1979
Robert J. Ireland   +2 more
openalex   +1 more source

Reaction Engineering of In Vitro Natural Product Biosynthesis: Challenges and Strategies

open access: yesChemBioChem, EarlyView.
The yield and turnover of in vitro natural product biosynthesis, and even its feasibility, are determined by intermolecular interactions. Reaction engineering allows to improve the performance of such complex biocatalytic systems. Natural products are widely used as pharmaceuticals and agrochemicals, or as active ingredients in food and cosmetics ...
Elsa Sánchez‐García   +2 more
wiley   +1 more source

Pyruvate kinase splice variants in fibroblasts influence cardiac remodeling after myocardial infarction in male mice. [PDF]

open access: yesJ Mol Cell Cardiol
Wells CK   +18 more
europepmc   +1 more source

Structure, function and inhibition of poly(ADP-ribose)polymerase, member 14 (PARP14) [PDF]

open access: yes, 2018
Levonis, Stephan M   +3 more
core   +1 more source

Recent Advances of In Situ Anticancer Nanomedicine from Enzyme‐Instructed Self‐Assembly

open access: yesChemNanoMat, EarlyView.
This review summarizes advances in enzymatic self‐assemblies for generating in situ anticancer nanomedicine over the past five years. It highlights the unique features of enzyme substrates for in situ anticancer nanomedicine by discussing the representative examples.
Linrui Zou, Meihui Yi, Bing Xu
wiley   +1 more source

Home - About - Disclaimer - Privacy